XGenomes
XGenomes is a healthcare diagnostics company based in Cambridge, MA, specializing in advanced DNA sequencing technologies aimed at providing high accuracy and cost-effective genetic analysis.
Company Overview
XGenomes, formerly known as XGenomes Corp., operates within the healthcare industry, specifically targeting the diagnostics sub-sector. With a small, dedicated team of 6, the company is situated in both Cambridge, MA, USA, and Cambridge, UK. XGenomes is part of the Y-Combinator W19 batch and has a regional presence in the United States, America/Canada, and offers remote or partly remote services.
Innovative DNA Sequencing Technology
XGenomes is developing cutting-edge technology for DNA sequencing that employs novel biochemistry, hardware, and algorithms. Their product features include zero library preparation, direct sequencing on single molecules of DNA, and integrated DNA extraction with sequencing. The company's technology aims to sequence both strands of the double-helix concurrently to produce DNA sequences with unprecedented accuracy. This development targets an in-depth identification of structural and single nucleotide variants, long-range haplotype phases, and genome 'dark matter' regions.
Cost-Efficient Sequencing Solutions
XGenomes is targeting a significant reduction in the cost of DNA sequencing, aiming for a cost of goods under $10. The company plans to initially offer access as a service to high-value customers and subsequently adopt a razor and blade model. This strategy involves selling sequencing instruments and consumables, making it cost-effective for continuous usage.
Mission of XGenomes
XGenomes' mission is to create an accessible platform for continuous health monitoring and disease detection throughout an individual's lifetime. By providing a reliable and affordable solution for DNA sequencing, the company aims to empower users with detailed genetic insights that can significantly improve healthcare outcomes.